Diagnostics News and Research

RSS

Study finds no major difference in effectiveness of two classes of drugs in peritoneal dialysis patients

With cardiovascular disease being the No. 1 cause of death in end-stage kidney disease patients on peritoneal dialysis, a new study examined two classes of medications commonly prescribed to prevent cardiovascular events in these patients and found no significant difference in outcomes.

9 Aug 2016

Researchers identify biophysical markers that may help improve treatments for sickle cell disease

An interdisciplinary, international group of researchers has found new biophysical markers that could help improve the understanding of treatments for sickle cell disease, a step toward developing better methods for treating the inherited blood disorder that affects an estimated 80,000 to 100,000 Americans each year.

8 Aug 2016

Quest Diagnostics introduces digital cognitive assessment tool to help physicians assess patients with dementia

Quest Diagnostics, the world's leading provider of diagnostic information services, today announced CogniSense, a digital cognitive assessment tool that aids in a physician's assessment, diagnosis and care management of individuals with cognitive dysfunction.

From Quest Diagnostics 8 Aug 2016

Studies show insurance status may impact patients' health outcomes following cancer diagnosis

Two new studies indicate that health insurance status may impact patients' health outcomes following a diagnosis of cancer.

8 Aug 2016

Siemens Healthineers launches fully-automated coagulation analyzer with PSI technology in the U.S.

Today, Siemens Healthineers Laboratory Diagnostics business launched the Sysmex CS-2500 System—a mid-volume, fully-automated coagulation analyzer with smartly-designed PSI technology—in major markets including the U.S. Together with Lab Alliance of Central New York, the first U.S. customer to install the high-volume Sysmex CS-5100 System, the company celebrated the availability of its new Sysmex CS Hemostasis System portfolio in the U.S.

4 Aug 2016

Study finds high rate of misuse of seizure and pain drug

With increasing public attention to overdose deaths and misuse of prescription medications in the United States, researchers today presented the results of a new study looking at abuse and misuse of gabapentin, a medication used to treat seizures and relieve nerve pain often associated with shingles.

3 Aug 2016

New biochip test helps identify individuals at increased risk of Alzheimer's disease

Researchers today unveiled results from a new blood test to help identify which patients are at an elevated risk of Alzheimer's disease.

3 Aug 2016

New Valley Fever testing technology developed by TGen and NAU receives U.S. patent

Valley Fever, a potentially deadly dust-borne fungal disease, should be easier to diagnose and treat thanks to a testing technology developed by the Translational Genomics Research Institute and Northern Arizona University, and now protected by a patent issued today by the U.S. Patent and Trademark Office.

3 Aug 2016

Penn's ADCC receives $8.8 million grant to continue research on treatment for AD and related dementias

The University of Pennsylvania's Alzheimer's Disease Core Center has been awarded an estimated $8.8 million over five years from the National Institute on Aging to continue its mission of investigating mechanisms, diagnostics, treatments and strategies for Alzheimer's Disease (AD) and related dementias including Parkinson's disease (PD), Parkinson's disease dementia (PDD), Lewy Body dementia (LBD) and frontotemporal lobar degeneration (FTLD).

3 Aug 2016

Cell-free DNA test could help identify liver transplant patients with acute rejection

Today, researchers presented findings at the 68th AACC Annual Scientific Meeting that DNA found circulating in the bloodstream—known as cell-free DNA—can be used to identify liver transplant patients with acute rejection with greater accuracy than conventional liver function tests.

1 Aug 2016

Bio-Rad expands product line by launching two human recombinant antigens

Bio-Rad Laboratories, Inc., a global provider of life science research and clinical diagnostic products, today announced the launch of two human recombinant antigens, expanding the company's portfolio of Critical Raw Materials for the in vitro diagnostics market.

1 Aug 2016

AACC introduces new journal to deliver advancements in translational laboratory medicine research

AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce the launch of its new journal, The Journal of Applied Laboratory Medicine: An AACC Publication.

1 Aug 2016

Ortho Clinical Diagnostics to showcase seven posters of vital tests, six products at AACC meeting

Ortho Clinical Diagnostics today announced it will present seven scientific posters on its assays and display six products at its booth at the 2016 American Association for Clinical Chemistry annual meeting.

30 Jul 2016

AACC 2016: DRG International to exhibit Optimized Saliva ELISA Assays for measuring steroids

DRG International, a leading international medical diagnostic company, will showcase the Newly Optimized DRG Saliva ELISA Assays at the 2016 AACC in Philadelphia, Pennsylvania from August 02-04.

30 Jul 2016

Abingdon Health appoints JoyingBio as distributor of PCRD lateral flow immunoassays in China

Abingdon Health Ltd is pleased to announce the appointment of JoyingBio as distributor in China for PCRD nucleic acid lateral flow immunoassays (NALFIA).

30 Jul 2016

DRG International to display Hepcidin 25 (bioactive) HS ELISA Kit at 2016 AACC Expo

DRG International, a leading international medical diagnostic company, will showcase the NEW DRG Hepcidin 25 (bioactive) HS (High Sensitive) ELISA Kit (EIA-5782) at the 2016 AACC in Philadelphia, Pennsylvania from August 02-04.

30 Jul 2016

NxGEN and NX Prenatal collaborate to develop blood test for identifying women at risk of preterm birth

In a collaborative move to expand their women's health screening and testing portfolios, NxGEN MDx, LLC., and NX Prenatal Inc., announced a joint partnership to collaborate on the development and deployment of a blood test to assess pregnancy biomarkers of preterm birth risk.

30 Jul 2016

Diagnostics News and Research

Study finds no major difference in effectiveness of two classes of drugs in peritoneal dialysis patients

Researchers identify biophysical markers that may help improve treatments for sickle cell disease

Quest Diagnostics introduces digital cognitive assessment tool to help physicians assess patients with dementia

Studies show insurance status may impact patients' health outcomes following cancer diagnosis

Siemens Healthineers launches fully-automated coagulation analyzer with PSI technology in the U.S.

Study finds high rate of misuse of seizure and pain drug

New biochip test helps identify individuals at increased risk of Alzheimer's disease

New Valley Fever testing technology developed by TGen and NAU receives U.S. patent

Penn's ADCC receives $8.8 million grant to continue research on treatment for AD and related dementias

Cell-free DNA test could help identify liver transplant patients with acute rejection

Bio-Rad expands product line by launching two human recombinant antigens

AACC introduces new journal to deliver advancements in translational laboratory medicine research

Ortho Clinical Diagnostics to showcase seven posters of vital tests, six products at AACC meeting

AACC 2016: DRG International to exhibit Optimized Saliva ELISA Assays for measuring steroids

Abingdon Health appoints JoyingBio as distributor of PCRD lateral flow immunoassays in China

DRG International to display Hepcidin 25 (bioactive) HS ELISA Kit at 2016 AACC Expo

NxGEN and NX Prenatal collaborate to develop blood test for identifying women at risk of preterm birth

UK Export Award winner BBI Solutions to attend 2016 AACC

DRG International to present Aldosterone ELISA Kit at 2016 AACC

Express Diagnostics Int'l announces start of operations at new subsidiary in Bulgaria

Industry Focus eBook - Biotechnology (4th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News